Navigation Links
The Neutraceutical Company, LLC Grows Wellness Enhancement Business with Acquisition of North Dakota Based Trimlife.com
Date:1/30/2009

FORT LEE, N.J., Jan. 30 /PRNewswire/ -- The assets of Trimlife (www.trimlife.com), a nutritional supplement company founded in 1999, have been acquired by The Neutraceutical Company, LLC of Fort Lee, NJ, commonly known as 'TNC.' (www.tncllc.com). Trimlife offered the successful weight-loss product Lipitone (www.lipitone.com) and other supplements.

TNC plans to grow the Lipitone franchise as well as introduce additional wellness products and services on an aggressive timetable, with a concentration on quality and safety. "Successful products such as Lipitone achieved their market position by being free of dangerous chemicals and unpleasant side effects," remarked Jerry Stone, Managing Member of TNC. "Our expansion will focus on healthy, organic, natural aids to common issues affecting many of us. Our mandate is to encourage 'healthy living' through products and information that promote wholesome lifestyles."

One new extension to the product line is Lipitone Advanced, which marks a step forward for the well-known Lipitone franchise. The new Advanced formulation still contains the clinically tested fat-blocking and carb-blocking herbal ingredients that reduce calories and cholesterol, but now a mild metabolism boost has been added to increase energy levels. As a result, the customer has help in fighting off those food cravings throughout the day.

"Customers are pleased at how we've changed Lipitone," added Mr. Stone, "but we're focused on a broader message and product set. Achieving better health isn't just for today; we believe that taking care of your health can actually slow the aging process and a lifelong commitment to healthy living could mean a longer life." With that in mind, TNC is introducing new products, formulations, and ideas about wellness, including a new 7-step wellness program now in the final stages of development.

About TNC

The Neutraceutical Company LLC (www.tncllc.com) is a leading wellness enrichment company, dedicated to providing nutritionally-focused products and information of the highest quality.

TNC believes that vital health and health-based issues can be addressed using a balanced approach that combines moderate diet and exercise choices with wholesome products and supplements derived from natural plants and foods.

Coupling effective, high-quality supplements with outstanding service and support, and prudent and proactive advice and recommendations, TNC enhances the quality of life for their customers by empowering them to protect and improve their own health and well-being.

Statements in this release have not been evaluated by the FDA.


'/>"/>
SOURCE The Neutraceutical Company, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
2. Tela Sourcing, Inc., an Adaptis Company, Acquires HealthASPex Business
3. Nevada company, ORNL develop potential lifesaver
4. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
5. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
6. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
7. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
8. His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States
9. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
10. Hawaiis Premier Physician Management Company, TeamPraxis, Selects Allscripts Electronic Health Record for Statewide Deployment
11. Global Med Technologies(R), Inc. Announces the Sale of Approximately 3.3 Million Shares of Global Med Common Stock Held by SingXpress Ltd., an Asian Company, to Five American Institutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... Robert E. Burke, MD, PhD, had a successful career as a pediatrician ... could have led him down a much different path. , In his book, “Beyond ... Pediatrics,” Dr. Burke shares a personal account of the tribulations he encountered on his ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has long ... company involved in the underground testing of nuclear weapons. Years later, when her co-workers ... of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by agencies ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... an overview on laser diffraction analysis as a tool to characterize particle size ... and potential to obtain improved results and novel scientific findings. It describes methods ...
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based retail electric company ... Power's RCE (Residential Customer Equivalent) count exceeds 150,000. , Discount Power ... customers and 2,250 RCEs at the time of acquisition. In the three years ...
(Date:2/27/2017)... San Francisco, CA (PRWEB) , ... February 27, ... ... transplant clinic serving San Francisco and environs, is proud to announce an upgrade ... research information on the upgraded Yelp page on topics as diverse as Platelet ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
Breaking Medicine Technology: